AirXpanders completes manufacturing transfer to Costa Rica


AirXpanders LogoAirXpanders announced that it has transferred its manufacturing to a contract manufacturer in Costa Rica to produce its AeroForm breast tissue expansion system. The manufacturing capability for the device at the facility is now operational.

The production facility will help the company manufacture AeroForm expanders more cost-efficiently to produce a higher volume. AeroForm is currently available in more than 100 hospitals in the U.S.

The Costa Rica production line can produce up to 20,000 units per year and is owned and operated by MedPlast. AirXpanders plans to keep its California manufacturing facility that can produce up to 4,000 units per year.

AirXpnders touts AeroForm as a needle-free system to expand tissue and enable breast reconstruction for women who have had mastectomies.

“Creating access to AeroForm for every eligible patient is mission critical for us, and our new manufacturing capacity supports our ability to make that happen,” Scott Dodson, president and CEO of AirXpanders, said in a press release. “We are delighted to have delivered on our commitment to open the Costa Rica manufacturing facility, enabling us to meet the growing demand for AeroForm and pave the way for improvements in gross margins. The scale of the Medplast facility gives us the ability to readily add additional manufacturing lines for added capacity as we broaden our sales and marketing activities across the U.S. and around the world.”

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks Boston on Oct. 2.)

NEW! Technology Track at DeviceTalks Boston

textadimage These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.

View Technology Track Featured Sessions

Register today to save. Use code TECHTRACK to save an additional 10%.

Speak Your Mind